News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

This rate exceeds the survival ... 19th cycle of therapy. The Phase 2 study enrolled 54 heavily pre-treated metastatic breast cancer patients who received the Bria-IMT regimen plus checkpoint ...

Advances in breast cancer diagnosis and treatment in the last 70 years have considerably increased the survival rate to 18.7 per ... such as hormone therapy for ER-positive cancers, HER2-targeted ...

Neoadjuvant therapy is the therapy you receive before your main treatment or surgery. Their research suggested that neoadjuvant therapy with a combination of ribociclib and letrozole could be an ...

Novartis NVS announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (EMA) recommended granting approval to the breast cancer drug Kisqali ...

In the US, five-year relative survival rates now exceed 91% ... removing hormonal sources could block breast cancer growth, paving the way for hormone therapy. In the 1940s, radiation therapy ...

This industry symposium took place during the European Society for Medical Oncology (ESMO) Congress held in Barcelona, Spain, from 13 th –17 th September 2024. Schmid has received consulting fees from ...